by FiveSenses | Feb 29, 2024 | News Release
Vancouver, BC, Canada, February 29th 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), one of the leading Canadian biotechnology companies working in the field of immune-oncology, is pleased to announce the... 
by Defence Therapeutics | Feb 1, 2024 | News Release
Vancouver, BC, Canada, January 30th, 2024 – Defence Therapeutics Inc. (“Defence” or the “Company”), one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces the closing of the 1st tranche of its previously announced... by FiveSenses | Feb 1, 2024 | Communiqué de presse
Vancouver, C.-B., Canada, 30 janvier 2024 – Defence Therapeutics Inc. (« Defence » ou la « Société »), l’une des principales entreprises de biotechnologie canadiennes œuvrant dans le développement de vaccins et de technologies d’administration de médicaments...
Recent Comments